Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations
January 25 2022 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced the hiring of Darren Greenfield to serve
as the Company’s Senior Director of Seed Operations. In this newly
created position, Mr. Greenfield will be responsible for Camelina
seed scale up and commercial contract production. He brings over 25
years of experience with major agriculture companies managing the
development and commercial production of proprietary canola plant
varieties. He also brings experience with identity preserved supply
chains for specialty products based on his work at Dow Agrosciences
with high oleic canola oil. He joins Yield10 from BASF Canada, Inc.
“We are delighted to welcome Darren to our team and will rely on
his significant experience and successful track record leading seed
operations and establishing production contracts with growers in
our commercial launch geography,” said Oliver Peoples, Ph.D.,
President and Chief Executive Officer of Yield10. “We look forward
to his contributions as we scale up our current lead Camelina
varieties and progress improved varieties including herbicide
tolerant lines in our development and commercialization pipeline.
Our primary goal is to establish the Camelina seed supply chain and
address the growing global demand for biofuel feedstock oils and
protein meal. We expect that the development and commercialization
of these seed products will be followed by the launch of our
EPA/DHA omega-3 nutritional oil and PHA bioplastics Camelina plant
varieties as our proprietary traits are brought online.”
“The team at Yield10 has done impressive work to date in
establishing a differentiated Camelina seed trait and product
pipeline as well as in developing spring and winter lines of Elite
Camelina with good seed yield and oil content as a basis for
transitioning to early commercial development,” said Mr.
Greenfield. “I look forward to introducing growers to Camelina and
successfully driving adoption of the crop in the U.S. and
Canada.”
Mr. Greenfield has extensive experience contracting and working
with growers in Canada, the U.S. and South America as well as
building supply chain and inventory operations. From January to
December 2021, he was senior certified canola production agronomist
at BASF Canada Inc. From 2018 to 2020, he was seed production
manager and a member of the senior executive team at Cibus Canada,
ULC where he managed grower contracting, seed production, packaging
and shipping for canola operations. From 2010 to 2018, Mr.
Greenfield held various positions at Dow Agrosciences Canada, Inc
where he was most recently canola operations leader for Nexera™, a
canola trait, where he directed all aspects of canola seed
operations. He was also a member of the Canola and Business
Leadership teams during his tenure at Dow Agrosciences. Mr.
Greenfield is a Professional Agrologist and a Certified Crop
Advisor.
About Yield10
BioscienceYield10 Bioscience, Inc. is an agricultural
bioscience company that is using its differentiated trait gene
discovery platform, the “Trait Factory”, to develop improved
Camelina varieties for the production of proprietary seed products,
and to discover high value genetic traits for the agriculture and
food industries. Our goals are to efficiently establish a high
value seed products business based on developing superior varieties
of Camelina to produce feedstock oils, nutritional oils, and PHA
bioplastics, and to license our yield traits to major seed
companies for commercialization in major row crops, including corn,
soybean and canola. Yield10 is headquartered in Woburn, MA and has
an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please
visit www.yield10bio.com, or follow the Company
on Twitter, Facebook and LinkedIn.
(YTEN-G)
Safe Harbor
for Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, expectations related to seed scale up, establishment of
a Camelina seed supply chain, launch of a Camelina seed operation
and business, product development and future licensing
arrangements, as well as the overall progress of Yield10
Bioscience, Inc., constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those anticipated, including the risks and uncertainties
detailed in Yield10 Bioscience's filings with the Securities and
Exchange Commission. Yield10 assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the matters described herein.
Contacts: Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Jul 2023 to Jul 2024